2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management

por Ali, Haris, Bacigalupo, Andrea
Publicado 2021

Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation

por Salhotra, Amandeep, Yuan, Shan, Ali, Haris
Publicado 2023

Oral Chronic Graft-versus-Host Disease in Post-Hematopoietic Stem Cell Transplant Patients Following SARS-CoV-2 Vaccination: Case Reports

por Epstein, Joel B., Hernandez, Raymond S., Nakamura, Ryotaro, Yost, Susan E., Ali, Haris
Publicado 2023

Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients

por Ayaz, Ahmed, Arshad, Ainan, Malik, Hajra, Ali, Haris, Hussain, Erfan, Jamil, Bushra
Publicado 2020

P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034

por Ali, Haris, Kishtagari, Ashwin, Maher, Keri, Mohan, Sanjay, Prchal, Josef, Wang, Xulong, Chamoun, Kamal, Tantravahi, Srinivas
Publicado 2023

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients

por Ali, Haris, Ngo, Dat, Aribi, Ahmed, Arslan, Shukaib, Dadwal, Sanjeet, Marcucci, Guido, Nakamura, Ryotaro, Forman, Stephen J., Chen, Jason, Al Malki, Monzr M.
Publicado 2021

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study

por Ngo, Dat, Chen, Jason, Tinajero, Jose, Aribi, Ahmed, Arslan, Shukaib, Marcucci, Guido, Nakamura, Ryotaro, Al Malki, Monzr M., Forman, Stephen J., Dadwal, Sanjeet, Ali, Haris
Publicado 2023

P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS

por Gagelmann, Nico, Gupta, Vikas, Mclornan, Donal P, Bose, Prithviraj, Vachhani, Pankit, Kathrin Al-Ali, Haifa, Ali, Haris, Treskes, Philipp, Buckley, Sarah, Roman-Torres, Karisse, Scott, Bart
Publicado 2023

A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement

por Mehta, Rohtesh S., Ali, Haris, Dai, Yang, Yao, Bert, Overman, Bethany, Ratanatharathorn, Voravit, Gill, Saar, Socié, Gerard, Anderson, Kevin, Cahn, Jean Yves, Mujeebuddin, Arshad, Champlin, Richard, Shpall, Elizabeth, Holtan, Shernan G., Alousi, Amin
Publicado 2023

COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome

por Rahmanuddin, Syed, Jamil, Asma, Chaudhry, Ammar, Seto, Tyler, Brase, Jordyn, Motarjem, Pejman, Khan, Marjaan, Tomasetti, Cristian, Farwa, Umme, Boswell, William, Ali, Haris, Guidaben, Danielle, Haseeb, Rafay, Luo, Guibo, Marcucci, Guido, Rosen, Steven T., Cai, Wenli
Publicado 2023

P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE...

por Bose, Prithviraj, Mohan, Sanjay, Oh, Stephen, Gotlib, Jason, Ritchie, Ellen, Shimomura, Taizo, Ali, Haris, Boyer, Francoise, Guglielmelli, Paola, Hunter, Anthony M., Lamothe, Betty, Cui, Yi, Seguy, Francis, Mcbride, Amanda, Palandri, Francesca, Takeuchi, Masahiro, Kiladjian, Jean-Jacques
Publicado 2023

State-transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid Leukemia (CML)

por Frankhouser, David E., Rockne, Russell C., Uechi, Lisa, Zhao, Dandan, Branciamore, Sergio, O’Meally, Denis, Izarriy, Jihyun, Ghoda, Lucy, Ali, Haris, Trent, Jeffery M., Forman, Stephen, Fu, Yu-Hsuan, Kuo, Ya-Huei, Zhang, Bin, Marcucci, Guido
Publicado 2023

Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia

por Ladbury, Colton, Semwal, Hemal, Hong, Daniel, Yang, Dongyun, Hao, Claire, Han, Chunhui, Liu, An, Marcucci, Guido, Rosenthal, Joseph, Hui, Susanta, Salhotra, Amandeep, Ali, Haris, Nakamura, Ryotaro, Stein, Anthony, Al Malki, Monzr, Wong, Jeffrey Y. C., Dandapani, Savita
Publicado 2022

Tacrolimus initial steady state level in post-transplant cyclophosphamide based GvHD prophylaxis regimens

por Yao, Janny M., Yang, Dongyun, Clark, Mary C., Otoukesh, Salman, Cao, Thai, Ali, Haris, Arslan, Shukaib, Aldoss, Ibrahim, Artz, Andrew, Amanam, Idoroenyi, Salhotra, Amandeep, Pullarkat, Vinod, Sandhu, Karamjeet, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Al Malki, Monzr M.
Publicado 2022

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

por Aldoss, Ibrahim, Pillai, Raju, Yang, Dongyun, Yang, Lixin, Arslan, Shukaib, Mokhtari, Sally, Malki, Monzr M. Al, Salhotra, Amandeep, Shahani, Shilpa, Ali, Haris, Mei, Matthew, Artz, Andrew, Snyder, David, Afkhami, Michelle, Armenian, Saro, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pullarkat, Vinod
Publicado 2021

Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study

por Ali, Haris, Tsai, Ni-Chun, Synold, Timothy, Mokhtari, Sally, Tsia, Weimin, Palmer, Joycelynne, Stiller, Tracey, Al Malki, Monzr, Aldoss, Ibrahim, Salhotra, Amandeep, Rahmanuddin, Syed, Pullarkat, Vinod, Cai, Ji-Lian, Stein, Anthony, Forman, Stephen J., Marcucci, Guido, Mei, Matthew, Snyder, David S., Nakamura, Ryotaro
Publicado 2022

Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide

por Al Malki, Monzr M., Palmer, Joycelynne, Tsai, Ni-Chun, Mokhtari, Sally, Hui, Susanta, Tsai, Weimin, Aldoss, Ibrahim, Ali, Haris, Aribi, Ahmed, Cao, Thai, Mei, Mathew, Sandhu, Karamjeet S., Siddiqi, Tanya, Forman, Stephen J., Nakamura, Ryotaro, Marcucci, Guido, Stein, Anthony, Wong, Jeffrey Y. C., Rosenthal, Joseph
Publicado 2022

Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transpl...

por Aldoss, Ibrahim, Stiller, Tracey, Tsai, Ni-Chun, Song, Joo Y., Cao, Thai, Bandara, N. Achini, Salhotra, Amandeep, Khaled, Samer, Aribi, Ahmed, Al Malki, Monzr M., Mei, Matthew, Ali, Haris, Spielberger, Ricardo, O’Donnell, Margaret, Snyder, David, Slavin, Thomas, Nakamura, Ryotaro, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Publicado 2018

Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration

por Jain, Tania, Tsai, Hua-Ling, Elmariah, Hany, Vachhani, Pankit, Karantanos, Theodoros, Wall, Sarah, Gondek, Lukasz, Bashey, Asad, Keyzner, Alla, Tamari, Roni, Grunwald, Michael, Abedin, Sameem, Nadiminti, Kalyan, Iqbal, Madiha, Gerds, Aaron, Viswabandya, Auro, McCurdy, Shannon, Malki, Monzr Al, Varadhan, Ravi, Ali, Haris, Gupta, Vikas, Jones, Richard John, Otoukesh, Salman
Publicado 2023

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience

por Amanam, Idoroenyi, Yao, Janny, Puing, Alfredo, Tsai, Ni‐Chun, Samuels, Diana, Ngo, Dat, Ho, Stephanie, Ali, Haris, Aribi, Ahmed, Arslan, Shukaib, Artz, Andrew, Htut, Myo, Koller, Paul, Salhotra, Amandeep, Sandhu, Karamjeet, Nikolaenko, Liana, Pawlowska, Anna, Shouse, Geoffrey, Stein, Anthony, Marcucci, Guido, Forman, Stephen, Nakamura, Ryotaro, Dadwal, Sanjeet, Al Malki, Monzr M.
Publicado 2023